105 related articles for article (PubMed ID: 9052383)
1. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors.
Kiss R; Dewitte O; Decaestecker C; Camby I; Gordower L; Delbecque K; Pasteels JL; Brotchi J; Salmon I
Am J Clin Pathol; 1997 Mar; 107(3):321-31. PubMed ID: 9052383
[TBL] [Abstract][Full Text] [Related]
2. Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables.
Decaestecker C; Salmon I; Dewitte O; Camby I; Van Ham P; Pasteels JL; Brotchi J; Kiss R
J Neurosurg; 1997 Mar; 86(3):532-7. PubMed ID: 9046312
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
4. Identification of high versus lower risk clinical subgroups in a group of adult patients with supratentorial anaplastic astrocytomas.
Decaestecker C; Salmon I; Camby I; Dewitte O; Pasteels JL; Brotchi J; Van Ham P; Kiss R
J Neuropathol Exp Neurol; 1995 May; 54(3):371-84. PubMed ID: 7745436
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
6. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins.
Camby I; Nagy N; Lopes MB; Schäfer BW; Maurage CA; Ruchoux MM; Murmann P; Pochet R; Heizmann CW; Brotchi J; Salmon I; Kiss R; Decaestecker C
Brain Pathol; 1999 Jan; 9(1):1-19. PubMed ID: 9989446
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
[TBL] [Abstract][Full Text] [Related]
9. Supratentorial gliomas: a comparative study by grade and histologic type.
Shaw EG; Scheithauer BW; O'Fallon JR
J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
[TBL] [Abstract][Full Text] [Related]
10. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of malignancy using SPECT with 201Tl chloride in astrocytic tumors].
Seo H; Fujita T; Nakai O; Komatani A
No To Shinkei; 1994 Feb; 46(2):168-74. PubMed ID: 8167054
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.
Montine TJ; Vandersteenhoven JJ; Aguzzi A; Boyko OB; Dodge RK; Kerns BJ; Burger PC
Neurosurgery; 1994 Apr; 34(4):674-8; discussion 678-9. PubMed ID: 8008166
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients.
Salmon I; Kiss R; Dewitte O; Gras T; Pasteels JL; Brotchi J; Flament-Durand J
Cancer; 1992 Jul; 70(2):538-46. PubMed ID: 1319820
[TBL] [Abstract][Full Text] [Related]
14. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms.
Montine TJ; Bruner JM; Vandersteenhoven JJ; Dodge RK; Burger PC
Diagn Mol Pathol; 1994 Dec; 3(4):240-5. PubMed ID: 7866633
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase expression in glial tumors: correlation with malignancy and tumor proliferation.
Tanriover N; Ulu MO; Isler C; Durak H; Oz B; Uzan M; Akar Z
Neurol Res; 2008 Nov; 30(9):940-4. PubMed ID: 18671896
[TBL] [Abstract][Full Text] [Related]
17. Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium.
Gilles FH; Brown WD; Leviton A; Tavaré CJ; Adelman L; Rorke LB; Davis RL; Hedley-Whyte TE
Cancer; 2000 Mar; 88(6):1477-83. PubMed ID: 10717633
[TBL] [Abstract][Full Text] [Related]
18. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
20. A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors.
Karak AK; Singh R; Tandon PN; Sarkar C
Pathol Oncol Res; 2000; 6(1):46-52. PubMed ID: 10749588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
